Portrait of Neha Seth
  • Telehealth visits
bch logo

Neha Seth, PT

Physical Therapy (Pediatric)
Portrait of Neha Seth
Portrait of Neha Seth
bch logo

Neha Seth, PT

Physical Therapy (Pediatric)
  • Telehealth visits

On this page

About me

Neha Seth is a physical therapist who cares for children in the hospital when they need rehabilitation services following an injury or illness. She has a special interest in working with patients who have pediatric amplified pain syndrome, an abnormal response of the nervous system that causes pain to be felt with great intensity.

Seth's research focuses on functional outcomes – measurable results involving physical ability – for patients with amplified pain syndrome.

Seth helped develop the UCSF Pediatric Amplified Pain Rehabilitation (PAPR) Program, in which specialists in various relevant disciplines collaborate to manage hospitalized patients’ pain and restore lost physical function. She continues working with these children through the outpatient Pediatric Pain Management Program to help each child recover to the best of their ability. She is passionate about working with children affected by amplified pain and brain injuries, and believes the body works best when there is a happy intent to its movements.

Seth has a master's degree in biokinesiology from the University of Southern California. She is a certified brain injury specialist and a pediatric certified specialist in physical therapy. She is a member of the American Physical Therapy Association (APTA) and APTA Pediatrics.

My expertise

  • Specialties
    • Physical Therapy (Pediatric)

Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.